Dayun Sui

2.2k total citations
96 papers, 1.8k citations indexed

About

Dayun Sui is a scholar working on Molecular Biology, Complementary and alternative medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Dayun Sui has authored 96 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 29 papers in Complementary and alternative medicine and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Dayun Sui's work include Ginseng Biological Effects and Applications (50 papers), Traditional Chinese Medicine Analysis (26 papers) and Natural product bioactivities and synthesis (15 papers). Dayun Sui is often cited by papers focused on Ginseng Biological Effects and Applications (50 papers), Traditional Chinese Medicine Analysis (26 papers) and Natural product bioactivities and synthesis (15 papers). Dayun Sui collaborates with scholars based in China, United Kingdom and United Arab Emirates. Dayun Sui's co-authors include Xiaofeng Yu, Huali Xu, Shaochun Qu, Wenwen Fu, Ping Yu, Siwei Zhang, Zeyuan Lu, Yi Wu, Ping Zhang and Yuchen Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Dayun Sui

96 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dayun Sui China 25 1.2k 361 304 216 188 96 1.8k
Xiaobo Sun China 27 1.1k 0.9× 296 0.8× 266 0.9× 134 0.6× 232 1.2× 57 1.9k
Mohamed M. Sayed‐Ahmed Saudi Arabia 29 784 0.7× 334 0.9× 384 1.3× 167 0.8× 275 1.5× 48 2.3k
Jialin Duan China 27 890 0.8× 214 0.6× 429 1.4× 116 0.5× 147 0.8× 60 1.8k
Chunhua Ma China 28 1.2k 1.0× 339 0.9× 268 0.9× 249 1.2× 97 0.5× 56 2.3k
Yongmei Liu China 20 727 0.6× 159 0.4× 291 1.0× 256 1.2× 236 1.3× 54 1.5k
Wanglin Jiang China 28 927 0.8× 246 0.7× 331 1.1× 135 0.6× 75 0.4× 72 2.0k
Lian‐Hua Fang China 24 694 0.6× 205 0.6× 246 0.8× 126 0.6× 152 0.8× 74 1.6k
Hamid Mollazadeh Iran 26 663 0.6× 266 0.7× 362 1.2× 202 0.9× 74 0.4× 49 2.0k
Chien‐Chun Li Taiwan 22 853 0.7× 231 0.6× 352 1.2× 157 0.7× 64 0.3× 57 1.9k

Countries citing papers authored by Dayun Sui

Since Specialization
Citations

This map shows the geographic impact of Dayun Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dayun Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dayun Sui more than expected).

Fields of papers citing papers by Dayun Sui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dayun Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dayun Sui. The network helps show where Dayun Sui may publish in the future.

Co-authorship network of co-authors of Dayun Sui

This figure shows the co-authorship network connecting the top 25 collaborators of Dayun Sui. A scholar is included among the top collaborators of Dayun Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dayun Sui. Dayun Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sui, Dayun, et al.. (2021). Ginsenoside Re Improves Inflammation and Fibrosis in Hepatic Tissue by Upregulating PPARγ Expression and Inhibiting Oxidative Stress in db/db Mice. Evidence-based Complementary and Alternative Medicine. 2021. 1–10. 15 indexed citations
2.
Xu, Huali, Wenwen Fu, Ying Xin, et al.. (2014). 20(S)-Protopanaxadiol Induces Human Breast Cancer MCF-7 Apoptosis through a Caspase-Mediated Pathway. Asian Pacific Journal of Cancer Prevention. 15(18). 7919–7923. 21 indexed citations
4.
Sui, Dayun. (2010). Protective effects of total flavonoids of sowthistle-leafixeris sedling on myocardial ischemia-reperfusion injury in rats. Zhongguo yaolixue tongbao. 6 indexed citations
5.
Xu, Huali, Xiaofeng Yu, Shaochun Qu, et al.. (2010). Anti-proliferative effect of Juglone from Juglans mandshurica Maxim on human leukemia cell HL-60 by inducing apoptosis through the mitochondria-dependent pathway. European Journal of Pharmacology. 645(1-3). 14–22. 95 indexed citations
6.
Sui, Dayun. (2009). Protective effects of panax quinquefolium 20s-protopanaxtriolsaponins on myocardial ischemia-reperfusion injury in rats. Journal of Jilin University. 1 indexed citations
7.
Xu, Huali, et al.. (2008). Leukogenic effect of tremella fuciformis spores polysaccharide on leukopenia mice. 34(5). 759–762. 2 indexed citations
8.
Sui, Dayun. (2008). Effect of Ginsenoside-Rb on Ventricular Remodeling in Rats with Pressure Overloaded Hypertrophic Myocardium and its Mechanism. Lishizhen Medicine and Materia Medica Research. 1 indexed citations
9.
Sui, Dayun. (2008). Inhibition of 20(S)-protopanaxadiol on proliferation of lung cancer A549 cells and tumor growth of nude mice. Zhongcaoyao. 1 indexed citations
10.
Sui, Dayun. (2008). Effect of Tremella fuciformis Spores Polysaccharides on Transplanated Tumor and Immunological Function in Mice. The Chinese Journal of Modern Applied Pharmacy. 1 indexed citations
11.
Sui, Dayun. (2008). Effect of 20(S)-Protopanaxadiol on SMMC-7721 human liver cancer in vivo and in vitro. Zhongguo yaolixue tongbao. 4 indexed citations
12.
Sui, Dayun. (2008). Study on Therapeutic Effects of Lugua Polypeptide Solution(LGPS) on Adjuvant Arthritis in Rats and its Mechanism. Zhōnghuá yàoxué zázhì. 1 indexed citations
13.
Sui, Dayun. (2007). Effects of TFAD on the blood-liquid metabolism in experimental hyperlipoproteinemia rats. Zhongguo yaolixue tongbao. 2 indexed citations
14.
Sui, Dayun. (2007). Effects of Ginsenoside-Rb on platelet aggregation and hemorheology in rats of acute blood stasis model. Zhongguo yaolixue tongbao. 3 indexed citations
15.
Sui, Dayun. (2005). Effect of sowthistle-leaf ixeris seedling saponins on blood lipid metabolism and antioxidative activity in experimental hyperlipidemia rats. 1 indexed citations
16.
Sui, Dayun. (2004). Effects of Acanthopanax senticosus saponins on myocardial ischemia-reperfusion arrhythmia in rats. 3 indexed citations
17.
Sui, Dayun, et al.. (2004). [Effects of ginsenoside-Rb on blood lipid metabolism and anti-oxidation in hyperlipidemia rats].. PubMed. 29(11). 1085–8. 16 indexed citations
18.
Sui, Dayun, et al.. (2004). Effects of Acanthopanax senticosus saponins on blood lipid metabolism and antioxidative activity in experimental hyperlipidemia rats. Journal of Jilin University. 30(1). 56–59. 2 indexed citations
19.
Sui, Dayun, et al.. (2002). Antimyocardial ischemic effects of Panax quinquefolium 20s-protopanaxdiol saponins (PQDS) and its mechanism. 37(2). 100–102. 1 indexed citations
20.
Liu, Shangyu, et al.. (2001). Effects of Panax quinquefolium 20s-protopanaxdiol saponins on the hemodynamics and cardial oxygen metabolism dogs with acute myocardial infarction. 36(1). 25–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026